Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benedict Panizza

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Oral Oncology|March 3, 2017
Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policySandro V Porceddu, Rob Milne, Elizabeth Brown, et al.
NPJ Precision Oncology|March 20, 2021
Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinomaCorey Smith, Margaret McGrath, Michelle A Neller, et al.
Anticancer Research|March 10, 2015
Ectopic expression of protein kinase C-β sensitizes head and neck squamous cell carcinoma to diterpene estersRyan A Adams, Marjorie M A D'Souza, Carly J Pierce, et al.
Head & Neck|November 15, 2011
Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapySandro V Porceddu, David I Pryor, Elizabeth Burmeister, et al.
Clinical and Vaccine Immunology : CVI|December 20, 2013
Cytotoxic T cell adoptive immunotherapy as a treatment for nasopharyngeal carcinomaViviana P Lutzky, Pauline Crooks, Leanne Morrison, et al.
Immunology and Cell Biology|May 27, 2009
Optimization of LMP-specific CTL expansion for potential adoptive immunotherapy in NPC patientsViviana P Lutzky, Joanne E Davis, Pauline Crooks, et al.
Science Translational Medicine|June 29, 2018
Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomasNatalia Saenz-Ponce, Rachael Pillay, Lilia Merida de Long, et al.
Frontiers in Oncology|July 22, 2024
A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinomaRahul Ladwa, Janin Chandra, Wai-Ping Woo, et al.
NPJ Precision Oncology|September 13, 2023
Deep spatial-omics analysis of Head & Neck carcinomas provides alternative therapeutic targets and rationale for treatment failureAndrew Causer, Xiao Tan, Xuehan Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2025
Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate StudyRahul Ladwa, Jenny H Lee, Margaret McGrath, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Oral Oncology|March 3, 2017
Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policySandro V Porceddu, Rob Milne, Elizabeth Brown, et al.
NPJ Precision Oncology|March 20, 2021
Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinomaCorey Smith, Margaret McGrath, Michelle A Neller, et al.
Anticancer Research|March 10, 2015
Ectopic expression of protein kinase C-β sensitizes head and neck squamous cell carcinoma to diterpene estersRyan A Adams, Marjorie M A D'Souza, Carly J Pierce, et al.
Head & Neck|November 15, 2011
Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapySandro V Porceddu, David I Pryor, Elizabeth Burmeister, et al.
Clinical and Vaccine Immunology : CVI|December 20, 2013
Cytotoxic T cell adoptive immunotherapy as a treatment for nasopharyngeal carcinomaViviana P Lutzky, Pauline Crooks, Leanne Morrison, et al.
Immunology and Cell Biology|May 27, 2009
Optimization of LMP-specific CTL expansion for potential adoptive immunotherapy in NPC patientsViviana P Lutzky, Joanne E Davis, Pauline Crooks, et al.
Science Translational Medicine|June 29, 2018
Targeting the XPO1-dependent nuclear export of E2F7 reverses anthracycline resistance in head and neck squamous cell carcinomasNatalia Saenz-Ponce, Rachael Pillay, Lilia Merida de Long, et al.
Frontiers in Oncology|July 22, 2024
A phase Ib study to assess the safety of the human papillomavirus DNA vaccine (AMV002) in combination with durvalumab for HPV-associated oropharyngeal squamous cell carcinomaRahul Ladwa, Janin Chandra, Wai-Ping Woo, et al.
NPJ Precision Oncology|September 13, 2023
Deep spatial-omics analysis of Head & Neck carcinomas provides alternative therapeutic targets and rationale for treatment failureAndrew Causer, Xiao Tan, Xuehan Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2025
Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate StudyRahul Ladwa, Jenny H Lee, Margaret McGrath, et al.
Pageof 6